Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne School of Population Health, Level 3, 207 Bouverie Street, Parkville, Victoria 3010, Australia.
Br J Cancer. 2011 Jun 28;105(1):162-9. doi: 10.1038/bjc.2011.172. Epub 2011 May 10.
Carriers of germline mutations in DNA mismatch repair (MMR) genes have a high risk of colorectal cancer (CRC), but the modifiers of this risk are not well established. We estimated an association between body mass index (BMI) in early adulthood and subsequent risk of CRC for carriers and, as a comparison, estimated the association for non-carriers.
A weighted Cox regression was used to analyse height and weight at 20 years reported by 1324 carriers of MMR gene mutations (500 MLH1, 648 MSH2, 117 MSH6 and 59 PMS2) and 1219 non-carriers from the Colon Cancer Family Registry.
During 122,304 person-years of observation, we observed diagnoses of CRC for 659 carriers (50%) and 36 non-carriers (3%). For carriers, the risk of CRC increased by 30% for each 5 kg m(-2) increment in BMI in early adulthood (hazard ratio, HR: 1.30; 95% confidence interval, CI: 1.08-1.58; P=0.01), and increased by 64% for non-carriers (HR: 1.64; 95% CI: 1.02-2.64; P=0.04) after adjusting for sex, country, cigarette smoking and alcohol drinking (and the MMR gene that was mutated in carriers). The difference in HRs for carriers and non-carriers was not statistically significant (P=0.50). For MLH1 and PMS2 (MutLα heterodimer) mutation carriers combined, the corresponding increase was 36% (HR: 1.36; 95% CI: 1.05-1.76; P=0.02). For MSH2 and MSH6 (MutSα heterodimer) mutation carriers combined, the HR was 1.26 (95% CI: 0.96-1.65; P=0.09). There was no significant difference between the HRs for MutLα and MutSα heterodimer carriers (P=0.56).
Body mass index in early adulthood is positively associated with risk of CRC for MMR gene mutation carriers and non-carriers.
携带 DNA 错配修复(MMR)基因突变的个体发生结直肠癌(CRC)的风险较高,但该风险的修饰因素尚未明确。我们评估了年轻时的体重指数(BMI)与 MMR 基因突变携带者(500 例 MLH1、648 例 MSH2、117 例 MSH6 和 59 例 PMS2)随后发生 CRC 的风险之间的关联,并作为比较,评估了非携带者的关联。
使用加权 Cox 回归分析了来自结肠癌家族登记处的 1324 名 MMR 基因突变携带者(500 例 MLH1、648 例 MSH2、117 例 MSH6 和 59 例 PMS2)和 1219 名非携带者在 20 岁时报告的身高和体重。
在 122304 人年的观察期间,我们观察到 659 名携带者(50%)和 36 名非携带者(3%)发生 CRC。对于携带者,年轻时 BMI 每增加 5kg/m²,CRC 风险增加 30%(风险比,HR:1.30;95%置信区间,CI:1.08-1.58;P=0.01),非携带者增加 64%(HR:1.64;95% CI:1.02-2.64;P=0.04),校正性别、国家、吸烟和饮酒(以及携带者突变的 MMR 基因)后。携带者和非携带者的 HR 差异无统计学意义(P=0.50)。对于 MLH1 和 PMS2(MutLα 异二聚体)突变携带者,相应的增幅为 36%(HR:1.36;95% CI:1.05-1.76;P=0.02)。对于 MSH2 和 MSH6(MutSα 异二聚体)突变携带者,HR 为 1.26(95% CI:0.96-1.65;P=0.09)。MutLα 和 MutSα 异二聚体携带者的 HR 无显著差异(P=0.56)。
年轻时的 BMI 与 MMR 基因突变携带者和非携带者 CRC 的风险呈正相关。